Showing 17,841 - 17,860 results of 130,204 for search '(( i e decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.35s Refine Results
  1. 17841

    A Dissolved Oxygen Threshold for Shifts in Bacterial Community Structure in a Seasonally Hypoxic Estuary by Rachel L. Spietz (782905)

    Published 2015
    “…Bacterial community composition across all samples was also strongly associated with the dissolved oxygen gradient, and significant changes in bacterial community composition occurred at a dissolved oxygen concentration between 5.18 and 7.12 mg O<sub>2</sub> L<sup>-1</sup>. …”
  2. 17842

    Vanadium(V<sup>IV</sup>)–Porphyrin-Based Metal–Organic Frameworks for Synergistic Bimetallic Activation of Inert C(sp<sup>3</sup>)–H Bonds by Yefei Wang (430888)

    Published 2022
    “…Herein, by decorating vanadium­(V<sup>IV</sup>)–porphyrin into metal–organic frameworks (MOFs) to stabilize the active tertbutyl peroxide radical, we reported a new approach to accomplish inert C­(sp<sup>3</sup>)–H bond activation by a synergistic bimetallic strategy via a hydrogen atom transfer process under mild conditions. …”
  3. 17843

    Example of a set of resistance profiles from a system with five strata and four antibiotics. by Sonja Lehtinen (784974)

    Published 2019
    “…<p>Each row in the table corresponds to the resistance profile of one isolate—i.e. there are three isolates from each strata (equal sampling/size of strata is not necessary). …”
  4. 17844
  5. 17845
  6. 17846

    Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial by Samuel Oliveira de Afonseca (12798419)

    Published 2022
    “…This study aimed to assess the effectiveness of vitamin E for prevention of oxaliplatin-induced peripheral neuropathy.DESIGN AND SETTINGProspective, phase II, randomized pilot study developed at a university hospital in the Greater ABC region.METHODSPatients were randomized five days before starting oxaliplatin treatment, to receive either vitamin E or placebo until the end of the chemotherapy regimen. …”
  7. 17847

    Kinetically Stable Single Crystals of Perovskite-Phase CsPbI<sub>3</sub> by Daniel B. Straus (1234383)

    Published 2019
    “…Unlike conventional semiconductors, the optical absorption and joint density-of-states of bulk γ-CsPbI<sub>3</sub> is greatest near the band edge and decreases beyond the <i>E</i><sub>g</sub> for at least 1.9 eV. …”
  8. 17848

    Kinetically Stable Single Crystals of Perovskite-Phase CsPbI<sub>3</sub> by Daniel B. Straus (1234383)

    Published 2019
    “…Unlike conventional semiconductors, the optical absorption and joint density-of-states of bulk γ-CsPbI<sub>3</sub> is greatest near the band edge and decreases beyond the <i>E</i><sub>g</sub> for at least 1.9 eV. …”
  9. 17849
  10. 17850

    Front-of-pack nutritional labels: Understanding by low- and middle-income Mexican consumers by Jorge Vargas-Meza (7878926)

    Published 2019
    “…<div><p>Front-of-pack labeling is a cost-effective strategy to decrease population consumption of sodium, sugar, saturated fat, total fat, and trans-fatty acids, considered critical nutrients for chronic disease. …”
  11. 17851
  12. 17852
  13. 17853
  14. 17854

    Genome-wide regulation of electro-acupuncture on the neural <i>Stat</i>5-loss-induced obese mice - Fig 4 by Shu-Ping Fu (549948)

    Published 2017
    “…<p>EA treatment altered the abnormally expressed genes both in the hypothalamus (A-E) and Epi-WAT of <i>Stat</i>5NKO mice (F-I). …”
  15. 17855
  16. 17856
  17. 17857
  18. 17858

    Cytotoxic potentiation by a MDR inhibitor. by Adam A. Friedman (812702)

    Published 2015
    “…Error bars represent s.d. of measurement replicates (<i>n</i> = 7). (G) Overexpression of MDR1 (compared to GFP control) in WM451Lu decreases sensitivity to vincristine, an effect reversible with 5μM lapatinib. …”
  19. 17859

    Figure S2 from Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR Inhibitors by Guoqing Qian (15095933)

    Published 2023
    “…<p>Osimertinib decreases PD-L1 mRNA levels (A-C) and exerts differential effects on reducing PD-L1 induced by EGF and INFg (D and E), which might increase PD-L1 via different mechanisms (F), in EGFRm NSCLC cells.…”
  20. 17860